Cytovas Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cytovas General Information


Developer of an informatics platform designed to analyze flow cytometry data. The company's platform Cloud Cytomics, mine flow cytometry data to identify correlations between cellular biomarkers and disease, enabling clinicians and drug developers an automated mining, analysis and interpretation of flow cytometry cell-based biomarker data.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA
  • United States
+1 (267) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytovas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Feb-2019 00000 Completed Out of Business
5. Later Stage VC 01-Jun-2017 0000 00000 Completed Generating Revenue
4. Grant 01-Jan-2014 00000 00000 Completed Startup
3. Accelerator/Incubator 05-Oct-2012 00000 00000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Cytovas’s complete valuation and funding history, request access »

Cytovas Patents

Cytovas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120214679-A1 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents Inactive 29-Nov-2010 0000000000
US-20120065912-A1 Calibration device and methods for use with a liquid handler Inactive 09-Sep-2010 00000000000 0
US-20110207119-A1 Methods for predicting a cancer patient's response to sunitinib Inactive 22-Feb-2010 00000000000 0
US-20110130302-A1 Biological pathways associated with chemotherapy outcome for breast cancer Inactive 01-Dec-2009 0000000000 0
US-20110129822-A1 Multi drug response markers for breast cancer cells Inactive 01-Dec-2009 C12Q1/6886 0
To view Cytovas’s complete patent history, request access »

Cytovas FAQs

  • When was Cytovas founded?

    Cytovas was founded in 2010.

  • Who is the founder of Cytovas?

    Wade Rogers Ph.D and Emile Mohler MD are the founders of Cytovas.

  • Where is Cytovas headquartered?

    Cytovas is headquartered in Philadelphia, PA.

  • What industry is Cytovas in?

    Cytovas’s primary industry is Biotechnology.

  • Is Cytovas a private or public company?

    Cytovas is a Private company.

  • What is Cytovas’s current revenue?

    The current revenue for Cytovas is 00000.

  • How much funding has Cytovas raised over time?

    Cytovas has raised $300K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »